Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).

Festa A, D'Agostino R Jr, Mykkänen L, Tracy RP, Zaccaro DJ, Hales CN, Haffner SM.

Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):562-8.

3.

Insulin resistance, inflammation, and the prediabetic state.

Haffner SM.

Am J Cardiol. 2003 Aug 18;92(4A):18J-26J. Review.

PMID:
12957323
4.

Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus.

Juhan-Vague I, Alessi MC, Vague P.

Ann Med. 1996 Aug;28(4):371-80. Review.

PMID:
8862693
5.

Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients.

Schneider DJ, Nordt TK, Sobel BE.

Diabetes. 1993 Jan;42(1):1-7. Review.

PMID:
8420806
6.

[Plasminogen activator inhibitor (PAI-1) and diabetes mellitus. II. PAI-1 in insulin resistant conditions].

Galajda P, Sutarík L, Vladár L, Stasko J, Kubisz P, Mokán M.

Vnitr Lek. 1998 Feb;44(2):111-4. Review. Slovak.

PMID:
9820087
7.
8.

Relationship between insulin resistance and coronary heart disease in diabetes mellitus and the general population: a critical appraisal.

Elliott TG, Viberti G.

Baillieres Clin Endocrinol Metab. 1993 Oct;7(4):1079-103. Review.

PMID:
8304914
9.

Atherosclerosis in diabetes: the role of hyperinsulinemia.

Stolar MW.

Metabolism. 1988 Feb;37(2 Suppl 1):1-9. Review.

PMID:
3277013
10.

[Plasminogen activator inhibitor (PAI-1) and diabetes mellitus. I. Regulation of PAI-1 levels].

Galajda P, Sutarík L, Vladár L, Stasko J, Kubisz P, Mokán M.

Vnitr Lek. 1997 Dec;43(12):804-8. Review. Slovak.

PMID:
9601894
11.

Hypertension as a metabolic disorder--an overview.

Smith U, Gudbjörnsdottir S, Landin K.

J Intern Med Suppl. 1991;735:1-7. Review.

PMID:
2043218
13.

Overview of the association between insulin and atherosclerosis.

Stout RW.

Metabolism. 1985 Dec;34(12 Suppl 1):7-12. Review.

PMID:
3906363
14.

Role of insulin and proinsulin in diabetic vascular disease.

Wareham NJ, Byrne CD, Hales CN.

Metabolism. 1995 Oct;44(10 Suppl 4):76-82. Review.

PMID:
7476316
15.

[Insulin resistance and hyperinsulinemia--clinical aspects].

Kozek E.

Przegl Lek. 1996;53(9):647-52. Review. Polish.

PMID:
8992530
16.

Impaired endogenous fibrinolysis in diabetes mellitus: mechanisms and therapeutic approaches.

Nordt TK, Bode C.

Semin Thromb Hemost. 2000;26(5):495-501. Review.

PMID:
11129405
17.

Hypofibrinolysis and the insulin resistance syndrome.

Vague P, Raccah D, Scelles V.

Int J Obes Relat Metab Disord. 1995 May;19 Suppl 1:S11-5. Review.

PMID:
7550531
18.

Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease.

Panahloo A, Yudkin JS.

Coron Artery Dis. 1996 Oct;7(10):723-31. Review. No abstract available.

PMID:
8970763
19.

Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease.

Panahloo A, Yudkin JS.

J Cardiovasc Risk. 1997 Apr;4(2):91-9. Review. No abstract available.

PMID:
9304490
20.

Role of intact proinsulin in diagnosis and treatment of type 2 diabetes mellitus.

Pfützner A, Pfützner AH, Larbig M, Forst T.

Diabetes Technol Ther. 2004 Jun;6(3):405-12. Review.

PMID:
15198846

Supplemental Content

Support Center